COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1285: Articles 12841-12850  | Next

Plasma cell-free DNA promise disease monitoring and tissue injury assessment of COVID-19
Jin, X., Wang, Y., Xu, J., Li, Y., Cheng, F., Luo, Y., Zhou, H., Lin, S., Xiao, F., Zhang, L., Lin, Y., Zhang, Z., Jin, Y., Zheng, F., Chen, W., Zhu, A., Tao, Y., Zhao, J., Kuo, T., Li, Y., Li, L., Wen, L., Ou, R., Li, F., Lin, L., Zhang, Y., Sun, J., Yuan, H., Zhuang, Z., Sun, H., Chen, Z., Li, J., Zhuo, J., Chen, D., Zhang, S., Sun, Y., Wei, P., Yuan, J., Xu, T., Yang, H., Wang, J., Xu, X., Zhong, N., Xu, Y., Sun, K., Zhao, J.
10.1101/2021.07.19.21260139 — Posted: 2021-07-22
Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: a mixed-methods study
Wilson, R., Quinn-Scoggins, H., Moriarty, Y., Hughes, J., Goddard, M., Cannings-John, R., Whitelock, V., Whitaker, K. L., Grozeva, D., Townson, J., Osborne, K., Smits, S., Robling, M., Hepburn, J., Moore, G., Gjini, A., Brain, K., Waller, J.
10.1101/2021.07.20.21260558 — Posted: 2021-07-22
Nutritional risk assessment using Malnutrition Universal Screening Tool (MUST) in COVID-19 patients: An observational study in a tertiary care hospital in Eastern India
NAG, S. M., BHOWMICK, S., BHOWMICK, S., DEB, U., KUNDU, D., RAY, K., KARPURKAYASTHA, S.
10.1101/2021.07.21.21260904 — Posted: 2021-07-22
CD8+ T cell signature in acute SARS-CoV-2 infection identifies memory precursors
Adamo, S., Michler, J., Zurbuchen, Y., Cervia, C., Taeschler, P., Raeber, M. E., Baghai Sain, S., Nilsson, J., Moor, A., Boyman, O.
10.1101/2021.07.22.453029 — Posted: 2021-07-22
B cell numbers predict humoral and cellular response upon SARS-CoV-2 vaccination among patients treated with rituximab
Stefanski, A.-L., Rincon-Arevalo, H., Schrezenmeier, E., Karberg, K., Szelinski, F., Ritter, J., Jahrsdoerfer, B., Schrezenmeier, H., Ludwig, C., Sattler, A., Kotsch, K., Chen, Y., Claussnitzer, A., Haibel, H., Proft, F., Guerra, G. M., Durek, P., Heinrich, F., Gomes, M. F., Burmester, G. R., Radbruch, A., Mashreghi, M.-F., Lino, A. C., Doerner, T.
10.1101/2021.07.19.21260803 — Posted: 2021-07-22
Turnover of SARS-CoV-2 lineages shaped the pandemic and enabled the emergence of new variants in the state of Rio de Janeiro, Brazil
Francisco Junior, R. d. S., Lamarca, A. P., de Almeida, L. G. P., Cavalcante, L., Machado, D. T., Martins, Y., Brustolini, O., Gerber, A. L., Guimaraes, A. P. d. C., Goncalves, R. B., Goncalves, C. C. A., Mariani, D., Cruz, T. F., de Souza, I. V., de Carvalho, E. M., Ribeiro, M. S., Carvalho, S., da Silva, F. D., Garcia, M. H. d. O., de Souza, L. M., da Silva, C. G., Ribeiro, C. L. P., Cavalcanti, A. C., de Mello, C. M. B., Struchiner, C. J., Tanuri, A., de Vasconcelos, A. T. R.
10.1101/2021.07.20.21260890 — Posted: 2021-07-22
Role of Multi-resolution Vulnerability Indices in COVID-19 spread: A Case Study in India
Bhattacharyya, R., Burman, A., Singh, K., Banerjee, S., Maity, S., Auddy, A., Rout, S. K., Lahoti, S., Panda, R., Baladandayuthapani, V.
10.1101/2021.07.19.21260791 — Posted: 2021-07-22
Potentially effective drugs for the treatment of COVID-19 in children: a systematic review
Wang, Z., Zhao, S., Tang, Y., Wang, Z., Shi, Q., Dang, X., Gan, L., Peng, S., Li, W., Zhou, Q., Li, Q., Mafiana, J. J., Cortes, R. G., Luo, Z., Liu, E., Chen, Y.
10.1101/2021.07.20.21260827 — Posted: 2021-07-22
Clusters consisting only of virus types with two mutations in the helicase found by Autoencoder analysis in Washington State, USA
Miyake, J., Yoshino, M., Sato, T., Niioka, H., Sakata, Y., Nakazawa, Y.
10.1101/2021.07.20.21260850 — Posted: 2021-07-22
BNT162b2 Vaccine Induces Divergent B cell responses to SARS-CoV-2 S1 and S2
Brewer, R. C., Ramadoss, N. S., Lahey, L. J., Robinson, W. H., Lanz, T. V.
10.1101/2021.07.20.21260822 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).